NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$20.00
$20.00
50-Day Range
$19.87
$20.00
52-Week Range
$12.26
$20.57
Volume
4,300 shs
Average Volume
765,906 shs
Market Capitalization
$843.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CSII stock logo

About Cardiovascular Systems Stock (NASDAQ:CSII)

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

CSII Stock News Headlines

The biggest energy story ever?
Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…
Cardiovascular Technologist Salary
The biggest energy story ever?
Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2023
Today
5/01/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.73%

Debt

Sales & Book Value

Annual Sales
$239.84 million
Book Value
$6.12 per share

Miscellaneous

Free Float
40,594,000
Market Cap
$843.96 million
Optionable
Optionable
Beta
0.74

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives


CSII Stock Analysis - Frequently Asked Questions

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.05. The medical device company had revenue of $61.45 million for the quarter, compared to the consensus estimate of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. The business's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.23) earnings per share.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

This page (NASDAQ:CSII) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners